Adjuvant Therapy in Acral Melanoma: A Systematic Review.

Clin Cosmet Investig Dermatol · 2024 · PMC11439362 · PMID 39345988

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In acral melanoma (n = 40), patients who received prior PEG-IFN therapy also showed a trend towards better clinical response to adjuvant pembrolizumab.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.